Molecular biology techniques for loss of heterozygosity detection: the glioma example
ABSTRACT In recent years, many oncology institutions have implemented the use of molecular approaches to assess and manage cancer patients. One commonly observed type of genetic alteration in cancer is the loss of heterozygosity (LOH). In the clinical setting, this molecular genetic marker is an imp...
Saved in:
Main Authors: | Tiago D. P. Ramos (Author), Lidia M. F. Amorim (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Patologia Clínica,
2015-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy
by: Xiaonan Zhang, et al.
Published: (2021) -
The Widely Used Antihelmintic Drug Albendazole is a Potent Inducer of Loss of Heterozygosity
by: Luiza S. E. P. Will Castro, et al.
Published: (2021) -
Characterization and clinical evaluation of microsatellite instability and loss of heterozygosity within tumor-related genes in colorectal cancer
by: Xueyun Huo, et al.
Published: (2021) -
Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing
by: Mojgan ATAEI-KACHOUEI, et al.
Published: (2015) -
Impact of 11q Loss of Heterozygosity Status on the Response of High-Risk Neuroblastoma With MYCN Amplification to Neoadjuvant Chemotherapy
by: Xian-Ying Lu, et al.
Published: (2022)